Capital World Investors
MRNA icon

Capital World Investors’s Moderna MRNA Stock Holding History

Capital World Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56B Buy
22,276,996
+3,579,302
+19% +$185M 0.18% 110
2026
Q1 		$950M Buy
18,697,694
+5,869,654
+46% +$274M 0.13% 146
2025
Q4 		$378M Buy
+12,828,040
New +$349M 0.05% 228
2024
Q3 		– Sell
-3,667,171
Closed -$435M – 556
2024
Q2 		$435M Buy
3,667,171
+19,054
+0.5% +$2.41M 0.07% 197
2024
Q1 		$389M Buy
3,648,117
+18,728
+0.5% +$1.89M 0.06% 225
2023
Q4 		$361M Sell
3,629,389
-338,342
-9% -$28.5M 0.06% 226
2023
Q3 		$410M Buy
3,967,731
+26,859
+0.7% +$3M 0.08% 205
2023
Q2 		$479M Buy
3,940,872
+21,282
+0.5% +$2.84M 0.09% 198
2023
Q1 		$602M Buy
3,919,590
+16,525
+0.4% +$2.73M 0.12% 170
2022
Q4 		$701M Buy
3,903,065
+2,002,125
+105% +$327M 0.15% 148
2022
Q3 		$225M Buy
1,900,940
+7,041
+0.4% +$1.07M 0.05% 256
2022
Q2 		$271M Buy
1,893,899
+9,504
+0.5% +$1.36M 0.06% 245
2022
Q1 		$325M Sell
1,884,395
-103,594
-5% -$17.4M 0.06% 249
2021
Q4 		$505M Sell
1,987,989
-622
-0% -$182K 0.08% 213
2021
Q3 		$765M Buy
1,988,611
+14
+0% +$5.16K 0.13% 170
2021
Q2 		$467M Buy
1,988,597
+172,115
+9% +$30.8M 0.08% 221
2021
Q1 		$238M Buy
+1,816,482
New +$263M 0.04% 278

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Capital World Investors's MRNA Position: Q2 2026 in Review

Capital World Investors increased its Moderna (MRNA) stake by 19% in Q2 2026, buying an estimated $185M and bringing the position to 22,276,996 shares worth $1.56B. The position accounts for 0.18% of the portfolio, ranked #110.

Capital World Investors first reported a position in MRNA in Q1 2021 and has held it in 17 quarters since. 614 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Capital World Investors held 22,276,996 shares of Moderna worth $1.56B as of Q2 2026.
  • Capital World Investors bought 3,579,302 Moderna shares in Q2 2026, an estimated $185M.
  • Moderna made up 0.18% of Capital World Investors's portfolio in Q2 2026, its #110 holding.
  • Capital World Investors first reported a position in Moderna in Q1 2021 and has held it in 17 quarters since.
  • 614 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.